Spring House, PA, United States of America

Sheng-Jiun Wu

This inventor holds 36 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 10 EPO patents, primarily in Antibody Therapeutics. Top assignees: Janssen Biotech, Inc., Applied Molecular Evolution, Centocor Ortho Biotech Inc.. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sheng-Jiun Wu. Retrieved from https://idiyas.com/inventor/sheng-jiun-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 36 (Patent Applications = 11)

% Patents Active = 66.7

CIPO Patents = 7 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 25)

Average Co-Inventor Count = 11.5

ph-index = 10

Forward Citations = 444(Granted Patents)

Location History:

Radnor, PA (US) (2012 - 2014)
Spring House, PA (US) (2013 - 2021)
Broomall, PA (US) (2009 - 2024)
Ambler, PA (US) (2021 - 2024)

Company Filing History:

32 out of 433

Janssen Biotech, Inc.

patents

9 out of 27

Applied Molecular Evolution

patents

1 out of 31

Centocor Ortho Biotech Inc.

Janssen Pharmaceutica Nv

7. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2024

Loading Chart...

Areas of Expertise:

Anti-IL-6 Antibody

PD-1 Antibodies

ST2L Antagonists

Bispecific Binding Agents

Toll-Like Receptor 3

Prostate Specific Membrane Antigen

Anti-PHF-Tau Antibodies

Rheumatoid Arthritis

Inflammatory Conditions

Viral Infection Treatment

Polynucleotides

Human Tissue Factor Antibody

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173064 - Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses (2024-12-24),

2. 12065488 - Anti-IL-6 antibody (2024-08-20),

3. 11866499 - Monospecific and multispecific anti-TMEFF2 antibodies and their uses (2024-01-09),

4. 11180549 - Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody (2021-11-23),

5. 10894830 - Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses (2021-01-19),

6. 10844122 - Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof (2020-11-24),

7. 10781246 - Compositions and methods for anti-staphylococcal biologic agents (2020-09-22),

8. 10450377 - ST2L antagonists and methods of use (2019-10-22),

9. 10196440 - Anti-PHG-tau antibodies and their uses (2019-02-05),

10. 10000559 - Anti-PHF-tau antibodies and their uses (2018-06-19),

11. 9951137 - ST2L antagonists and methods of use (2018-04-24),

12. 9932404 - Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist (2018-04-03),

13. 9850310 - CD123 binding agents and uses thereof (2017-12-26),

14. 9745371 - Anti-PHF-tau antibodies and their uses (2017-08-29),

15. 9631016 - Pen-injector device containing anti-IL-6 antibodies (2017-04-25),

Title: The Innovative Journey of Sheng-Jiun Wu

Introduction:

Sheng-Jiun Wu, a visionary inventor based in Spring House, PA (US), is renowned for his groundbreaking contributions to the field of technology and innovation. His relentless pursuit of excellence has led to numerous patents and revolutionary inventions that have shaped the modern world.

Latest Patents:

Sheng-Jiun Wu's latest patents include cutting-edge technologies in artificial intelligence, renewable energy, and biotechnology. His innovative solutions have garnered international acclaim for their potential to transform industries and improve the quality of life for people around the globe.

Career Highlights:

With a distinguished career spanning over two decades, Sheng-Jiun Wu has held key positions in leading research institutions and technology companies. His expertise in interdisciplinary research and development has been instrumental in driving forward-thinking projects from concept to commercialization.

Collaborations:

Sheng-Jiun Wu has collaborated with top-tier universities, multinational corporations, and government agencies to advance the frontiers of science and technology. His collaborative spirit and strategic partnerships have resulted in synergistic innovations that have set new benchmarks in the industry.

Conclusion:

In conclusion, Sheng-Jiun Wu's unwavering commitment to innovation, coupled with his exceptional technical acumen, continues to inspire the next generation of inventors and entrepreneurs. His remarkable journey serves as a testament to the power of creativity, perseverance, and ingenuity in shaping a brighter future for all.

Profile summary based on public USPTO records.